Correlation Between Pharvaris and Orchestra BioMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Pharvaris and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Orchestra BioMed.

Diversification Opportunities for Pharvaris and Orchestra BioMed

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pharvaris and Orchestra is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Pharvaris i.e., Pharvaris and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Pharvaris and Orchestra BioMed

Given the investment horizon of 90 days Pharvaris is expected to generate 2.07 times less return on investment than Orchestra BioMed. But when comparing it to its historical volatility, Pharvaris BV is 1.43 times less risky than Orchestra BioMed. It trades about 0.01 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  751.00  in Orchestra BioMed Holdings on September 2, 2024 and sell it today you would lose (188.00) from holding Orchestra BioMed Holdings or give up 25.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Orchestra BioMed Holdings

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Orchestra BioMed Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Orchestra BioMed is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pharvaris and Orchestra BioMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Orchestra BioMed

The main advantage of trading using opposite Pharvaris and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.
The idea behind Pharvaris BV and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing